PTIX 8-K 2026-11-06

Protagenic Therapeutics, Inc.\new (PTIX) 8-K dated 2026-11-06 — accession 0001493152-26-050420.

Protagenic Therapeutics, Inc.\new (PTIX) common stock.

Protagenic Therapeutics, Inc.\new filed a 8-K on 2026-11-06. Accession 0001493152-26-050420.

This 8-K covers: Material agreement (Item 1.01), New debt obligation (Item 2.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PTIX revenue for 2026-03-31 was $0. Net income was $1.4M.

Not investment advice. The PTIX SEC hub lists recent forms. The stock page is the research view.